An evidence-driven classification of nonfiltering ingredients for topical photoprotection
This article provides an evidence-driven classification of nonfiltering photoprotective ingredients that modulate the skin’s biological response to sunlight.
Authors
- Henry W. Lim (ORCID: https://orcid.org/0000-0002-1576-1115)
- Anthony Brown (ORCID: https://orcid.org/0000-0002-1271-310X)
- Yolanda Gilaberte (ORCID: https://orcid.org/0000-0001-8034-3617)
- Corinne Granger (ORCID: https://orcid.org/0000-0001-5117-448X)
- Thierry Passeron (ORCID: https://orcid.org/0000-0002-0797-6570)
- Carles Trullàs (ORCID: https://orcid.org/0000-0003-1925-5102)
- Giovanni Leone (ORCID: https://orcid.org/0000-0001-6120-2712)
- Jaime Piquero‐Casals (ORCID: https://orcid.org/0000-0002-4481-5602)
- Sérgio Schalka (ORCID: https://orcid.org/0000-0003-2425-7962)
- Jean Krutmann (ORCID: https://orcid.org/0000-0001-8433-1517)
Institutions
- Henry Ford Health System (US)
- Inserm (FR)
- Universidad de Zaragoza (ES)
- Centre Hospitalier Universitaire de Nice (FR)
- Polaris (United States) (US)
- Leibniz Institute of Environmental Medicine (DE)
- Hospital Universitario Miguel Servet (ES)
- Centre Méditerranéen de Médecine Moléculaire (FR)
- Skin Research Center (FR)
- Ospedale Israelitico (IT)
- Isdin (Spain) (ES)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2025-02-13
- DOI
- https://doi.org/10.1093/bjd/ljaf055
- Citations
- 5
- Primary Topic
- Skin Protection and Aging
- Type
- article
- Field-Weighted Citation Impact
- 10.02
Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Sanofi
- L'Oreal USA
- Patient-Centered Outcomes Research Institute
- Celgene
- Les Laboratories Pierre Fabre
- Incyte
- Astellas Pharma
- Galderma
- Symrise
- LEO Pharma
- Leibniz-Gemeinschaft